Investor's Business Daily96d agobearish
Why Gilead's High-Profile HIV Drug Might Have To Play Catch-UpNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com185d agobearish
Gilead Earnings Show HIV Drugs Continue to Shine. Why the Guidance Cut?Reuters185d agobearish
Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions